RICHARD H SCHELLER
CIK 1214133 · See Remarks · last filed 2026-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.71M
Companies
8
Total Filings
82
Lifetime Open-Market Net
-$26.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALEC | Director | 134,899 | $1.52 | $205.0K | -$2.39M | 16 | 2026-06-17 |
| MAZE | Director | 0 | $27.22 | $0 | -$464.0K | 3 | 2026-06-10 |
| Chrome Holding Co. (ME) Delisted | Director | 44,798 | $0.61 | $27.2K | -$59.7K | 6 | 2024-08-28 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 0 | $47.55 | $0 | -$3.24M | 4 | 2023-08-09 |
| BBIO | Director | 55,126 | $83.48 | $4.60M | -$9.47M | 16 | 2023-02-21 |
| ORIC | Director | 40,423 | $11.34 | $458.2K | -$275.8K | 7 | 2021-05-24 |
| XENE | Director | 7,000 | $62.95 | $440.7K | $19.9K | 7 | 2019-09-18 |
| DNA | EVP-RESEARCH | 0 | $7.57 | $0 | -$10.60M | 19 | 2008-07-18 |
Recent Filings · Page 8 of 9
82 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-10-24 | DNA | Mixed | — | -$77.6K | EDGAR |
| 2007-10-24 | DNA | Mixed | −1,500 | -$274.1K | EDGAR |
| 2007-10-24 | DNA | Mixed | −1,400 | -$153.6K | EDGAR |
| 2007-10-24 | DNA | Mixed | −1,500 | -$285.4K | EDGAR |
| 2007-10-24 | DNA | Mixed | −500 | -$199.4K | EDGAR |
| 2007-10-24 | DNA | Mixed | −800 | -$480.4K | EDGAR |
| 2007-10-24 | DNA | Mixed | −1,700 | -$262.6K | EDGAR |
| 2007-09-24 | DNA | Grant (A) | — | $0 | EDGAR |
| 2007-04-18 | DNA | Mixed | −1,200 | -$318.7K | EDGAR |
| 2007-04-18 | DNA | Mixed | −1,800 | -$791.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.